Theis Muncholm Thillemann

Use of medications and risk of revision after primary total hip arthroplasty

Publikation: Bidrag til bog/antologi/rapport/proceedingBidrag til bog/antologiForskningpeer review

Standard

Use of medications and risk of revision after primary total hip arthroplasty. / Thillemann, Theis Muncholm.

Engelsk. Bind 80 338. udg. 2009. s. 1-36 (Acta Orthopaedica. Supplementum ).

Publikation: Bidrag til bog/antologi/rapport/proceedingBidrag til bog/antologiForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Thillemann TM. Use of medications and risk of revision after primary total hip arthroplasty. I Engelsk. 338 udg. Bind 80. 2009. s. 1-36. (Acta Orthopaedica. Supplementum ). doi: 10.3109/17453670903448240

Author

Thillemann, Theis Muncholm. / Use of medications and risk of revision after primary total hip arthroplasty. Engelsk. Bind 80 338. udg. 2009. s. 1-36 (Acta Orthopaedica. Supplementum ).

Bibtex

@inbook{e384b6315dec480dbe95c70ae25c2d22,
title = "Use of medications and risk of revision after primary total hip arthroplasty",
keywords = "Animals, Arthroplasty, Replacement, Hip/adverse effects, Bone and Bones/drug effects, Diphosphonates/pharmacology, Diuretics/adverse effects, Fracture Healing/drug effects, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology, Prognosis",
author = "Thillemann, {Theis Muncholm}",
year = "2009",
month = dec,
doi = "10.3109/17453670903448240",
language = "English",
volume = "80",
series = "Acta Orthopaedica. Supplementum ",
publisher = "Taylor & Francis A B",
pages = "1--36",
booktitle = "Engelsk",
edition = "338",

}

RIS

TY - CHAP

T1 - Use of medications and risk of revision after primary total hip arthroplasty

AU - Thillemann, Theis Muncholm

PY - 2009/12

Y1 - 2009/12

KW - Animals

KW - Arthroplasty, Replacement, Hip/adverse effects

KW - Bone and Bones/drug effects

KW - Diphosphonates/pharmacology

KW - Diuretics/adverse effects

KW - Fracture Healing/drug effects

KW - Humans

KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology

KW - Prognosis

U2 - 10.3109/17453670903448240

DO - 10.3109/17453670903448240

M3 - Book chapter

C2 - 21110778

VL - 80

T3 - Acta Orthopaedica. Supplementum

SP - 1

EP - 36

BT - Engelsk

ER -